New MRI method aims to spot fake tumor growth in rectal cancer treatment

NCT ID NCT07381322

Recruiting now Knowledge-focused Sponsor: Peiyi Xie Source: ClinicalTrials.gov ↗

First seen Feb 02, 2026 · Last updated May 20, 2026 · Updated 16 times

Summary

This study is looking for 300 people with rectal cancer who are about to start immunotherapy. The goal is to see if combining multiple MRI scans and blood tests can help doctors tell the difference between a real tumor growing and a harmless 'pseudoprogression' that sometimes looks like growth but isn't. This is an observational study, not a treatment trial, so it aims to improve how we monitor the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Locations

Sixth affiliated hospital, Sun Yat-sen University
NOT_YET_RECRUITING

Guangzhou, Guangdong, 510655, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Xinyi People's hospital
RECRUITING

Maoming, Guangdong, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

RECTAL RECTAL CANCER